ABSTRACT
The cancer clinical therapy of doxorubicin (Dox) treatment is limited by its life-threatening cardiotoxic effects. Dickkopf-1 (Dkk1), the founding and best-studied member of the Dkk family, functions as an antagonist of canonical Wnt/β-catenin. Dkk1 is considered to play a broad role in a variety of biological processes, but its effects on Dox-induced cardiomyopathy are poorly understood. Here, we found that the level of Dkk1 was significantly increased in Dox-treated groups, and this increase exacerbated Dox-induced cardiomyocyte apoptosis and mitochondrial dysfunction. Overexpressing Dkk1 aggravated Dox-induced cardiotoxicity in H9C2 cells. Similar results were detected when adding active Dkk1 protein extracellularly. Conversely, adding specific antibody blocking extracellular Dkk1 attenuated the cardiotoxic response to Dox. Adenovirus encoding Dkk1 was transduced through intramyocardial injection and exacerbated Dox-induced cardiomyocyte apoptosis, mitochondrial damage and heart injury in vivo. Furthermore, Wnt/β-catenin signaling was inhibited during Dox-induced cardiotoxicity, and the re-activation of β-catenin prevented the effect of overexpressed Dkk1 and Dox-induced cardiotoxicity. In conclusion, these results reveal the crucial role of the Dkk1–Wnt/β-catenin signaling axis in the process of Dox-induced cardiotoxicity and provide novel insights into the potential mechanism of cardiomyopathy caused by clinical application of Dox.
Footnotes
Competing interests
The authors declare no competing or financial interests.
Author contributions
Conceptualization: L.L., J.L., P.L.; Methodology: L.L., Y.T., P.W., Z.G., Q.W., K.G., R.L.; Software: L.L., Y.T., P.W., Z.G.; Validation: L.L., J.L., P.L.; Formal analysis: L.L., J.L., P.L.; Investigation: L.L., P.W., Z.G., Q.W., K.G., R.L.; Resources: J.L., H.L., P.L.; Data curation: L.L., Y.T.; Writing - original draft: L.L.; Writing - review & editing: Y.T., J.L., P.L.; Visualization: L.L., P.W., Z.G.; Supervision: J.L., P.L.; Project administration: J.L., P.L.; Funding acquisition: J.L., H.L., P.L.
Funding
This research was supported by grants from the National Natural Science Foundation of China (81803521, 81872860, 81673433), Indigenous Innovative Research Team of Guangdong Province (2017BT01Y093), the National Major Special Projects for the Creation and Manufacture of New Drugs (2018ZX09301031-001), the Special Program for Applied Science and Technology of Guangdong Province (2015B020232009), the National Engineering and Technology Research Center for New Drug Druggability Evaluation (Seed Program of Guangdong Province, 2017B090903004), the Guangzhou Science and Technology Program Project (201604020121), Medical Scientific Research Foundation of Guangdong Province (A2018078), the Traditional Chinese Medicine Bureau of Guangdong Province (20191060) and the Natural Science Foundation of Guangdong Province (2017A030310542).
Supplementary information
Supplementary information available online at http://jcs.biologists.org/lookup/doi/10.1242/jcs.228478.supplemental
- Received December 2, 2018.
- Accepted April 9, 2019.
- © 2019. Published by The Company of Biologists Ltd
Log in using your username and password
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$30.00 .
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Subject collections
Other journals from The Company of Biologists
Cell scientist to watch – Vaishnavi Ananthanarayanan
Vaishnavi Ananthanarayanan is an Assistant Professor at the Centre for BioSystems Science and Engineering and the Indian Institute of Science. She also recently became an EMBO Young Investigator and Wellcome Trust/DBT – India Alliance Intermediate Fellow. Her research is focused on understanding dynein activation in living cells and the roles of microtubules in mitochondrial dynamics during neurodegeneration. She talks about her research, the importance of good mentors and much more.
Anna Akhmanova and Michel O. Steinmetz provide an overview of the current knowledge on the structure, interactions and functions of cellular factors that specifically interact with microtubule minus ends, and that regulate their dynamics and organization.
Mole - Dignity I
“What can we do to make dignity and respect part of what we do? Let's talk about that.”
Journal of Cell Science (JCS), Journal of Cell Biology (JCB) and Molecular Biology of the Cell (MBoC) announce a new manuscript transfer option that will empower authors whose manuscripts have been declined to seamlessly transfer their manuscripts and associated peer review reports between the journals.
Journal of Cell Science is pleased to welcome submissions for an upcoming special issue on 'Cell Biology of the Immune System' edited by Ana-Maria Lennon-Duménil. We invite you to showcase your breakthrough research on all aspects of cell biology as it relates to the immune system. The articles within this issue will receive extensive exposure to a broad audience of cell biologists and immunologists. Extended submission deadline: 15 August 2019.
preLights - Actin chromobody imaging reveals sub-organellar actin dynamics
Mariana De Niz highlights a preprint from Uri Manor and colleagues who use nanobody technology for live imaging of sub-organellar actin dynamics at previously unachieved temporal and spatial resolution, and explore its relevance for organelle fission.
Catch up with other recent preLights selected for the cell science community.
Articles of interest in our sister journals
A V0-ATPase-dependent apical trafficking pathway maintains the polarity of the intestinal absorptive membrane
Aurélien Bidaud-Meynard, Ophélie Nicolle, Markus Heck, Yann Le Cunff, Grégoire Michaux
Development 2019 146: dev174508
Physical and functional cell-matrix uncoupling in a developing tissue under tension
Amsha Proag, Bruno Monier, Magali Suzanne
Development 2019 146: dev172577